Cancer

Biotech Elaine Chen

STAT Plus: ASCO 2024: FDA oncology head wants clinical trials to range beyond China alone

Biotech Adam Feuerstein

STAT Plus: With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment

Health Angus Chen

How can hospitals boost cancer screening rates? Researchers report that an AI helped

The Readout Meghana Keshavan

STAT Plus: The surprising outperformance of a new drug against existing competitors, and other biotech updates

Biotech Matthew Herper

STAT Plus: For one rare type of lung cancer, Pfizer pill reduces progression by 81%

The Readout Meghana Keshavan

STAT Plus: Biotech’s most interesting fundraisings from the last week

In the Lab Angus Chen

STAT Plus: ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care

The Readout Meghana Keshavan

STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years

Biotech Angus Chen and Jonathan Wosen

STAT Plus: FDA advisers endorse Guardant Health’s colon cancer screening test

Biotech Allison DeAngelis

STAT Plus: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical

Matt's Take Matthew Herper

New data show the HPV vaccine prevents cancer in men, too. Why don’t more people get it?

Adam's Take Adam Feuerstein

STAT Plus: Setting the table: What to expect at this year’s ASCO meeting

Biotech Andrew Joseph

STAT Plus: At a flashy new research hub, AstraZeneca lays out ambitious growth goals

In the Lab Angus Chen

Black Americans’ risk for breast cancer gains clarity in analysis of 40,000 genomes

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: PDS Biotech’s survival benefit is absurdly overstated

Biotech Andrew Joseph

STAT Plus: Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S.

The Readout Elaine Chen

STAT Plus: Leqembi gets closer to being offered as an injection

Pharmalot Ed Silverman

STAT Plus: Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

Health Nicholas Florko

After decades fighting Big Tobacco, Cliff Douglas now leads a foundation funded by his former adversaries

First Opinion Patrick Skerrett

First Opinion essay on colorectal cancer screening: letter and response

Biotech Jonathan Wosen

STAT Plus: Exact Sciences’ stock tumbles amid worries cancer detection firm’s growth may slow

Pharmalot Ed Silverman

STAT Plus: A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available

In the Lab Nicholas St. Fleur

Q&A: Meet Catriona Jamieson, the scientist sending tumors into space

Letters to the editor Patrick Skerrett

Readers respond to funding academic medical centers, the ‘residency research arms race,’ and more

First Opinion Barron H. Lerner

Why isn’t there agreement on when women need to start getting mammograms?

Biotech Elaine Chen

STAT Plus: BridgeBio spins out oncology company as it focuses on heart drug

Biotech Allison DeAngelis

STAT Plus: Novartis extends radiopharma plans with $1 billion acquisition

In the Lab Angus Chen

STAT Plus: Biological clocks could be the key to longer, healthier lives. But scientists don’t yet agree on what ‘aging’ is

First Opinion Simone Ledward-Boseman

Colorectal cancer is increasing among young people. It’s time to boost research on it